ICO
Closing Date:

Seeking Druggable Targets and Technologies to Monitor Glomerular Filtration Rate in Chronic Kidney Disease and Acute Kidney Injury

Seeking Druggable Targets and Technologies to Monitor Glomerular Filtration Rate in Chronic Kidney Disease and Acute Kidney Injury

Johnson & Johnson, a global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify druggable targets in Chronic Kidney Disease and Acute Kidney Injury.

Research Interests

  • Chronic Kidney Disease: Mechanisms of action that reduce proteinuria by enhancing podocyte/endothelial integrity, reduce renal inflammation/fibrosis, and/or enhance tissue regeneration
  • Acute Kidney Injury: Opportunities associated with clinical stage assets are of high interest
  • Acute Kidney Injury...

To see the full details and submit your response please register now

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Technology
  • Academic Researcher
  • Centre of Excellence
  • Research Project
  • Spinout Company

Essential Information

Submission Form

Register Now

Share this call with professional partners.